Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

Autor: Judson, I., Radford, J. A., Harris, M., Blay, J. Y., Hoesel, Q. van, Cesne, A. le, Oosterom, A. T. van, Clemons, M. J., Kamby, C., Hermans, C.
Zdroj: European Journal of Cancer; 2001, Vol. 37 Issue: 7 p870-877, 8p
Databáze: Supplemental Index
Externí odkaz: